Cargando…
Accuracy and precision assessment for activity quantification in individualized dosimetry of (177)Lu-DOTATATE therapy
BACKGROUND: In order to obtain a reliable (177)Lu-DOTATATE therapy dosimetry, it is crucial to acquire accurate and precise activity measurements with the radionuclide calibrator, the SPECT/CT camera, and the NaI(Tl) well counter. The aim of this study was to determine, in a clinical context, the ac...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267757/ https://www.ncbi.nlm.nih.gov/pubmed/28127694 http://dx.doi.org/10.1186/s40658-017-0174-7 |
_version_ | 1782500690255413248 |
---|---|
author | Marin, Gwennaëlle Vanderlinden, Bruno Karfis, Ioannis Guiot, Thomas Wimana, Zena Flamen, Patrick Vandenberghe, Stefaan |
author_facet | Marin, Gwennaëlle Vanderlinden, Bruno Karfis, Ioannis Guiot, Thomas Wimana, Zena Flamen, Patrick Vandenberghe, Stefaan |
author_sort | Marin, Gwennaëlle |
collection | PubMed |
description | BACKGROUND: In order to obtain a reliable (177)Lu-DOTATATE therapy dosimetry, it is crucial to acquire accurate and precise activity measurements with the radionuclide calibrator, the SPECT/CT camera, and the NaI(Tl) well counter. The aim of this study was to determine, in a clinical context, the accuracy and the precision of their activity quantification over a range of activities and time. Ninety-three (177)Lu sources from the manufacturer were measured in the radionuclide calibrator over 2.5 years to evaluate its calibration accuracy and precision compared to the manufacturer’s value. A NEMA 2012/IEC 2008 phantom was filled with a (177)Lu activity concentration sphere-to-background ratio of five. It was acquired with the SPECT/CT camera to determine the reconstruction parameters offering the best compromise between partial volume effect and signal-to-noise ratio. The calibration factor was computed accordingly. The calibration quality was monitored over 2.5 years with 33 phantom acquisitions with activities ranging from 7040 to 0.6 MBq. Home-made sources were used to calibrate the well counter. Its reliability was evaluated with activities ranging from 150 to 0.2 kBq measured 34 times over 2.5 years. RESULTS: For the radionuclide calibrator, median [interquartile range] for the error on activity measurement was −0.99 [1.31] %. The optimal SPECT reconstruction parameters were obtained with 16 iterations, 16 subsets and a 12-mm Gaussian post-filter. The calibration factor was 9.87 cps/MBq with an error of −1.05 [2.12] %. The well counter was calibrated with 31.5 cps/kBq, and the error was evaluated to −12.89 [16.55] %. CONCLUSIONS: The accuracy and the precision of activity quantification using dedicated quality control were found to be sufficient for use in dosimetry implemented in clinical routine. The proposed methodology could be implemented in other centres to obtain reproducible (177)Lu-based treatment dosimetry. |
format | Online Article Text |
id | pubmed-5267757 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-52677572017-02-09 Accuracy and precision assessment for activity quantification in individualized dosimetry of (177)Lu-DOTATATE therapy Marin, Gwennaëlle Vanderlinden, Bruno Karfis, Ioannis Guiot, Thomas Wimana, Zena Flamen, Patrick Vandenberghe, Stefaan EJNMMI Phys Original Research BACKGROUND: In order to obtain a reliable (177)Lu-DOTATATE therapy dosimetry, it is crucial to acquire accurate and precise activity measurements with the radionuclide calibrator, the SPECT/CT camera, and the NaI(Tl) well counter. The aim of this study was to determine, in a clinical context, the accuracy and the precision of their activity quantification over a range of activities and time. Ninety-three (177)Lu sources from the manufacturer were measured in the radionuclide calibrator over 2.5 years to evaluate its calibration accuracy and precision compared to the manufacturer’s value. A NEMA 2012/IEC 2008 phantom was filled with a (177)Lu activity concentration sphere-to-background ratio of five. It was acquired with the SPECT/CT camera to determine the reconstruction parameters offering the best compromise between partial volume effect and signal-to-noise ratio. The calibration factor was computed accordingly. The calibration quality was monitored over 2.5 years with 33 phantom acquisitions with activities ranging from 7040 to 0.6 MBq. Home-made sources were used to calibrate the well counter. Its reliability was evaluated with activities ranging from 150 to 0.2 kBq measured 34 times over 2.5 years. RESULTS: For the radionuclide calibrator, median [interquartile range] for the error on activity measurement was −0.99 [1.31] %. The optimal SPECT reconstruction parameters were obtained with 16 iterations, 16 subsets and a 12-mm Gaussian post-filter. The calibration factor was 9.87 cps/MBq with an error of −1.05 [2.12] %. The well counter was calibrated with 31.5 cps/kBq, and the error was evaluated to −12.89 [16.55] %. CONCLUSIONS: The accuracy and the precision of activity quantification using dedicated quality control were found to be sufficient for use in dosimetry implemented in clinical routine. The proposed methodology could be implemented in other centres to obtain reproducible (177)Lu-based treatment dosimetry. Springer International Publishing 2017-01-26 /pmc/articles/PMC5267757/ /pubmed/28127694 http://dx.doi.org/10.1186/s40658-017-0174-7 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Marin, Gwennaëlle Vanderlinden, Bruno Karfis, Ioannis Guiot, Thomas Wimana, Zena Flamen, Patrick Vandenberghe, Stefaan Accuracy and precision assessment for activity quantification in individualized dosimetry of (177)Lu-DOTATATE therapy |
title | Accuracy and precision assessment for activity quantification in individualized dosimetry of (177)Lu-DOTATATE therapy |
title_full | Accuracy and precision assessment for activity quantification in individualized dosimetry of (177)Lu-DOTATATE therapy |
title_fullStr | Accuracy and precision assessment for activity quantification in individualized dosimetry of (177)Lu-DOTATATE therapy |
title_full_unstemmed | Accuracy and precision assessment for activity quantification in individualized dosimetry of (177)Lu-DOTATATE therapy |
title_short | Accuracy and precision assessment for activity quantification in individualized dosimetry of (177)Lu-DOTATATE therapy |
title_sort | accuracy and precision assessment for activity quantification in individualized dosimetry of (177)lu-dotatate therapy |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5267757/ https://www.ncbi.nlm.nih.gov/pubmed/28127694 http://dx.doi.org/10.1186/s40658-017-0174-7 |
work_keys_str_mv | AT maringwennaelle accuracyandprecisionassessmentforactivityquantificationinindividualizeddosimetryof177ludotatatetherapy AT vanderlindenbruno accuracyandprecisionassessmentforactivityquantificationinindividualizeddosimetryof177ludotatatetherapy AT karfisioannis accuracyandprecisionassessmentforactivityquantificationinindividualizeddosimetryof177ludotatatetherapy AT guiotthomas accuracyandprecisionassessmentforactivityquantificationinindividualizeddosimetryof177ludotatatetherapy AT wimanazena accuracyandprecisionassessmentforactivityquantificationinindividualizeddosimetryof177ludotatatetherapy AT flamenpatrick accuracyandprecisionassessmentforactivityquantificationinindividualizeddosimetryof177ludotatatetherapy AT vandenberghestefaan accuracyandprecisionassessmentforactivityquantificationinindividualizeddosimetryof177ludotatatetherapy |